A-EYE: A Mixed Quantitative and Qualitative Study to Develop and Evaluate the Application of Artificial Intelligence (AI) Methods Using Retinal Imaging for the Identification of Adverse Retinal Changes Associated With Cancer Therapies.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-18

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a data collection study involving the gathering of clinical data and OCT (optical coherence tomography) scans from 350 patients.

The purpose of this study is to gather data to help develop an AI algorithm to detect eye abnormalities specifically those related to certain cancer treatments.

At the end of the study interviews will be held with expert ophthalmologists to assess the acceptability of implementing AI into clinical practice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retinal Nerve Fiber Layer Thickness and Macular Thickness in Myopia, Hyperopia and Emmetropia : An OCT Study

NCT05486741

OCT Study RNFL and Macular Thickness

UNKNOWN

Real-world of AI in Diagnosing Retinal Diseases

NCT05981950

Artificial Intelligence Retinal Diseases

RECRUITING

Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases

NCT01546181

Retinal Dystrophies Age-related Macular Degeneration Arterial Hypertension +3 more

COMPLETED

Motivations and Barriers to Participating in Ophthalmology Research Projects

NCT04404803

Eye Diseases

UNKNOWN

Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.

NCT06877988

Visual Impairment

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many cancer patients will access new treatments through clinical trials. These treatments have often never been tested in humans and therefore, are likely to have unknown side effects. Some of these side effects include changes to the eye, such as blindness.

Ahead of patients taking part in these trials there is often little planning done to manage potential side effects on the eye. Additionally, accessing the expertise of eye specialists is not always available and often referral to a specialist is only given when eye symptoms have become advanced. These delays in identifying side effects on the eye also delays treatment and follow-up management. Providing patients access to this expertise would help in the detection and management of treatment side effects, however, due to demands on resources this access is not always readily available.

The aim of this study is to create an artificial intelligence (AI) program that can detect changes to the eye related to disease, which, in the future, can be specifically used in cancer patient care. Additionally, developing an AI program to detect cancer related side effects to the eye will go a significant way in easing the burden on the health care system and improve side effects from new cancer treatments.

This study will involve the collection of eye scans and medical data from participants at the Manchester Royal Eye Hospital. These will then be used to develop AI methods to detect changes in the eye related to those seen by patients on cancer treatment. The AI will then be compared with the assessments of eye specialists to assess if they give similar results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

All Comers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No Intervention

This is an observational study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Voluntary informed consent.
2. Aged at least 18 years.
3. Fully registered patient attending the Manchester Royal Eye Hospital
4. Patients are having an optical diagnostic imaging as part of their standard of care.

Exclusion Criteria

Patients are excluded from the study if any of the following criteria apply:

1\. Patient who are deemed clinically unable to be scanned by healthcare professional.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No